Humanigen
About:
Humanigen is a biopharmaceutical company that focuses on developing human antibody therapeutics.
Website: http://www.humanigen.com
Twitter/X: humanigen
Top Investors: Hercules Capital, Fidelity, Sofinnova Investments, Mitsubishi UFJ Capital, 5AM Ventures
Description:
Humanigen is a biopharmaceutical company that uses its biologic capabilities and its proprietary platform technology to develop first-in-class human antibody therapeutics. It focuses on preventing the serious and potentially life-threatening side-effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005.
$357M
Less than $1M
Burlingame, California, United States
2001-01-01
questions(AT)humanigen.com
Jeng Her, Robert Balint
11-50
2021-03-31
Public
© 2025 bioDAO.ai